Authors:
Rudolf, MP
Man, S
Melief, CJM
Sette, A
Kast, WM
Citation: Mp. Rudolf et al., Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7, CLIN CANC R, 7(3), 2001, pp. 788S-795S
Authors:
Nijman, HW
van Diest, PJ
Poort-Keesom, RJJ
von Mensdorff-Pouilly, S
Verstraeten, RA
Kummer, A
Meijer, CJLM
Melief, CJM
Hilgers, J
Kenemans, P
Citation: Hw. Nijman et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer, EUR J OB GY, 94(1), 2001, pp. 114-120
Authors:
van der Burg, SH
Kwappenberg, KMC
O'Neill, T
Brandt, RMP
Melief, CJM
Hickling, JK
Offringa, R
Citation: Sh. Van Der Burg et al., Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens, VACCINE, 19(27), 2001, pp. 3652-3660
Authors:
Medema, JP
de Jong, J
Peltenburg, LTC
Verdegaal, EME
Gorter, A
Bres, SA
Franken, KLMC
Hahne, M
Albar, JP
Melief, CJM
Offringa, R
Citation: Jp. Medema et al., Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors, P NAS US, 98(20), 2001, pp. 11515-11520
Authors:
den Boer, AT
Diehl, L
van Mierlo, GJD
van der Voort, EIH
Fransen, MF
Krimpenfort, P
Melief, CJM
Offringa, R
Toes, REM
Citation: At. Den Boer et al., Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance, J IMMUNOL, 167(5), 2001, pp. 2522-2528
Authors:
Schurmans, LRHM
Diehl, L
den Boer, AT
Sutmuller, RPM
Boonman, ZFHM
Medema, JP
van der Voort, EIH
Laman, J
Melief, CJM
Jager, MJ
Toes, REM
Citation: Lrhm. Schurmans et al., Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis, J IMMUNOL, 167(10), 2001, pp. 5832-5837
Authors:
Rea, D
Havenga, MJE
van den Assem, M
Sutmuller, RPM
Lemckert, A
Hoeben, RC
Bout, A
Melief, CJM
Offringa, R
Citation: D. Rea et al., Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells, J IMMUNOL, 166(8), 2001, pp. 5236-5244
Authors:
Ludewig, B
McCoy, K
Pericin, M
Ochsenbein, AF
Dumrese, T
Odermatt, B
Toes, REM
Melief, CJM
Hengartner, H
Zinkernagel, RM
Citation: B. Ludewig et al., Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells, J IMMUNOL, 166(6), 2001, pp. 3678-3687
Authors:
Herberts, CA
Stittelaar, KJ
van der Heeft, E
van Ganns-van den Brink, J
Poelen, MCM
Roholl, PJM
van Alphen, LJW
Melief, CJM
de Jong, APJM
van Els, CACM
Citation: Ca. Herberts et al., A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway, J GEN VIROL, 82, 2001, pp. 2131-2142
Authors:
Sutmuller, RPM
van Dulvenvoorde, LM
van Elsas, A
Schumacher, TNM
Wildenberg, ME
Allison, JP
Toes, REM
Offringa, R
Melief, CJM
Citation: Rpm. Sutmuller et al., Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses, J EXP MED, 194(6), 2001, pp. 823-832
Authors:
Medema, JP
Schuurhuis, DH
Rea, D
van Tongeren, J
de Jong, J
Bres, SA
Laban, S
Toes, REM
Toebes, M
Schumacher, TNM
Bladergroen, BA
Ossendorp, F
Kummer, JA
Melief, CJM
Offringa, R
Citation: Jp. Medema et al., Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: Differential modulation by T helper type 1 and type 2 cells, J EXP MED, 194(5), 2001, pp. 657-667
Authors:
van Elsas, A
Sutmuller, RPM
Hurwitz, AA
Ziskin, J
Villasenor, J
Medema, JP
Overwijk, W
Restifo, NP
Melief, CJM
Offringa, R
Allison, JP
Citation: A. Van Elsas et al., Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy, J EXP MED, 194(4), 2001, pp. 481-489
Authors:
Kessler, JH
Beekman, NJ
Bres-Vloemans, SA
Verdijk, P
van Veelen, PA
Kloosterman-Joosten, AM
Vissers, DCJ
ten Bosch, GJA
Kester, MGD
Sijts, A
Drijfhout, JW
Ossendorp, F
Offringa, R
Melief, CJM
Citation: Jh. Kessler et al., Efficient identification of novel HLA-A0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis, J EXP MED, 193(1), 2001, pp. 73-88
Authors:
Kleijmeer, M
Ramm, G
Schuurhuis, D
Griffith, J
Rescigno, M
Ricciardi-Castagnoli, P
Rudensky, AY
Ossendorp, F
Melief, CJM
Stoorvogel, W
Geuze, HJ
Citation: M. Kleijmeer et al., Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells, J CELL BIOL, 155(1), 2001, pp. 53-63
Authors:
van der Burg, SH
Ressing, ME
Kwappenberg, KMC
de Jong, A
Straathof, K
de Jong, J
Geluk, A
van Meugaarden, KE
Franken, KLMC
Ottenhoff, THM
Fleuren, GJ
Kenter, G
Melief, CJM
Offringa, R
Citation: Sh. Van Der Burg et al., Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes, INT J CANC, 91(5), 2001, pp. 612-618
Authors:
Heukamp, LC
van der Burg, SH
Drijfhout, JW
Melief, CJM
Taylor-Papadimitriou, J
Offringa, R
Citation: Lc. Heukamp et al., Identification of three non-VNTR MUC1-derived HLA-A0201-restricted T-cellepitopes that induce protective anti-tumor immunity in HLA-A2/K-b-transgenic mice, INT J CANC, 91(3), 2001, pp. 385-392
Authors:
van der Burg, SH
de Cock, K
Menon, AG
Franken, KLMC
Palmen, M
Redeker, A
Drijfhout, JW
Kuppen, PJK
van de Velde, CJH
Erdile, L
Tollenaar, RAEM
Melief, CJM
Offringa, R
Citation: Sh. Van Der Burg et al., Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer, EUR J IMMUN, 31(1), 2001, pp. 146-155
Authors:
Ressing, ME
van Driel, WJ
Brandt, RMP
Kenter, GG
de Jong, JH
Bauknecht, T
Fleuren, GJ
Hoogerhout, P
Offringa, R
Sette, A
Celis, E
Grey, H
Trimbos, BJ
Kast, WM
Melief, CJM
Citation: Me. Ressing et al., Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma, J IMMUNOTH, 23(2), 2000, pp. 255-266